Summary
This 8-K filing by Amgen Inc. (AMGN) on February 13, 2006, reports the company's unaudited financial results for the fourth quarter ended December 31, 2005, and its financial condition as of that date. Investors can find key details regarding the company's operational performance and balance sheet in the attached exhibits. The filing includes the Condensed Consolidated Statement of Operations, providing a look at revenue and expenses for the three months ended December 31, 2005, compared to the same period in 2004. Additionally, a detailed breakdown of product sales for the fourth quarter of 2005 and 2004 is provided, which is crucial for understanding revenue drivers. The Condensed Consolidated Balance Sheets offer a snapshot of Amgen's assets, liabilities, and equity at the end of 2005 and 2004, allowing for an assessment of the company's financial health and stability.
Key Highlights
- 1Amgen Inc. announced its unaudited financial results for the fourth quarter of 2005.
- 2The filing includes a Condensed Consolidated Statement of Operations for Q4 2005 and Q4 2004.
- 3Detailed product sales information for the three months ended December 31, 2005, and 2004, is provided.
- 4Condensed Consolidated Balance Sheets as of December 31, 2005, and December 31, 2004, are included.
- 5This report provides a look at the company's financial performance and position at the close of the 2005 fiscal year.
- 6The information is presented to fulfill reporting requirements for material events.
- 7The filing was made on February 13, 2006, with the earliest event reported on January 26, 2006.